All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
DUBLIN – Amryt Pharma plc raised $60 million in new equity financing to complete its all-stock takeover of Aegerion Pharmaceuticals Inc., creating a global rare diseases company with three marketed products, a U.S. commercial infrastructure and a couple of near-term opportunities to expand its portfolio.